Document Details

Filing Date
Oct 26, 2023
Document Date
Oct 26, 2023
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
Other
Company
BioLineRx
Issuer
BioLineRx Ltd.
Shape
Potential life-changing treatments are on the way

Each molecule in our development pipeline is carefully selected for its potential ability to improve upon the standard of care, delivering maximum value to patients